Skip to main content
. 2019 Mar 25;20(6):1483. doi: 10.3390/ijms20061483
AEs Adverse Events
ALM Acral Lentiginous Melanoma
BID Bis in Die
CI Confidence Interval
CNS Central Nervous System
CTCAE Common Terminology Criteria for Adverse Events
DTIC Dacarbazine
HR Hazard Ratio
LM Lentigo Maligna
NM Nodular Melanoma
ORR Overall Response Rate
OS Overall Survival
PFS Progression Free Survival
SSM Superficial Spreading Melanoma